Posterior reversible encephalopathy syndrome after anlotinib treatment for small cell lung cancer: A case report and literature review
Anlotinib is an oral multi-targeted tyrosine kinase inhibitor as a third-line and subsequent treatment for patients with small cell lung cancer (SCLC) in China. The neurotoxicity is less reported. Posterior reversible encephalopathy syndrome (PRES) is characterized by headaches, seizures, encephalop...
Sparad:
Huvudupphovsmän: | , , , , |
---|---|
Materialtyp: | Bok |
Publicerad: |
Frontiers Media S.A.,
2023-02-01T00:00:00Z.
|
Ämnen: | |
Länkar: | Connect to this object online. |
Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|
Internet
Connect to this object online.3rd Floor Main Library
Signum: |
A1234.567 |
---|---|
Exemplar 1 | Tillgänglig |